,Argument,positive,neutral,negative,No Argument
0,Revenue,2168.0,176.0,581.0,
1,Growth,2660.0,141.0,437.0,
2,Investments,375.0,39.0,90.0,
3,Market Conditions,476.0,280.0,841.0,
4,Competition,33.0,35.0,388.0,
5,Market Share,232.0,10.0,51.0,
6,User Engagement,123.0,4.0,27.0,
7,Regulations,16.0,9.0,92.0,
8,Cost Management,307.0,26.0,114.0,
9,Ad Revenue,19.0,2.0,9.0,
10,Earnings per Share,491.0,96.0,156.0,
11,Employees,8.0,2.0,10.0,
12,Market Expansion,147.0,4.0,3.0,
13,Innovation,197.0,15.0,18.0,
14,Cash Flow,423.0,74.0,172.0,
15,Long-term Growth,89.0,5.0,2.0,
16,Demand,99.0,23.0,66.0,
17,Expenses,51.0,24.0,171.0,
18,Margins,707.0,84.0,523.0,
19,Economic Conditions,13.0,25.0,111.0,
20,Debt Management,68.0,24.0,50.0,
21,Dividend Policy,77.0,10.0,35.0,
22,Share Buyback,73.0,6.0,1.0,
23,Shares Repurchase,43.0,4.0,1.0,
24,Balance Sheet,75.0,14.0,20.0,
25,Leadership,165.0,13.0,42.0,
26,Production,59.0,25.0,60.0,
27,Sustainability,31.0,0.0,3.0,
28,Risk,22.0,26.0,197.0,
29,Advertiser Strength,3.0,0.0,5.0,
30,Collaboration,28.0,2.0,2.0,
31,Mergers and Acquisition,41.0,10.0,18.0,
32,Quality,26.0,0.0,4.0,
33,Costs,20.0,11.0,170.0,
34,Pricing,60.0,17.0,58.0,
35,Profitability,146.0,11.0,54.0,
36,Risks,2.0,10.0,319.0,
37,Working Capital,6.0,1.0,4.0,
38,Inventory,22.0,12.0,40.0,
39,Prepayments,0.0,0.0,1.0,
40,Supply Chain,46.0,9.0,48.0,
41,Customers,2.0,0.0,0.0,
42,Technology Trends,31.0,1.0,4.0,
43,Market Positioning,115.0,9.0,14.0,
44,Core Business Evolution,1.0,0.0,0.0,
45,Margin Expansion,2.0,1.0,0.0,
46,Cybersecurity,1.0,0.0,1.0,
47,Retention,2.0,0.0,1.0,
48,Return On Equity,51.0,15.0,10.0,
49,Customer Acquisition,23.0,1.0,2.0,
50,Valuation,51.0,38.0,94.0,
51,Price/Earnings Ratio,8.0,8.0,20.0,
52,Sales Growth,162.0,9.0,52.0,
53,Consumer Pressure,1.0,0.0,2.0,
54,Operations,14.0,3.0,14.0,
55,Consumer Beauty,0.0,0.0,2.0,
56,Product Investment,0.0,0.0,1.0,
57,Global Presence,8.0,1.0,0.0,
58,Sales Pressure,0.0,0.0,2.0,
59,Inventory Management,9.0,6.0,5.0,
60,Sales Trends,12.0,1.0,5.0,
61,Consumer Demand,23.0,3.0,24.0,
62,Product Characteristics,46.0,6.0,14.0,
63,Product Innovation,26.0,0.0,4.0,
64,Acquisition Synergies,0.0,0.0,1.0,
65,Promotional Pressure,0.0,1.0,4.0,
66,Earnings Estimates,33.0,19.0,43.0,
67,Sales,119.0,16.0,133.0,
68,Fundamentals,9.0,0.0,4.0,
69,Performance,82.0,5.0,40.0,
70,Partnerships,139.0,8.0,6.0,
71,Research and Development,49.0,11.0,9.0,
72,Collaborations,11.0,0.0,0.0,
73,Earnings,384.0,68.0,212.0,
74,Proprietary Assets,8.0,0.0,1.0,
75,Phase 3 Results,3.0,1.0,0.0,
76,Potential Value,18.0,2.0,0.0,
77,Cash Position,30.0,6.0,4.0,
78,Market Opportunity,281.0,19.0,1.0,
79,Clinical Data,93.0,25.0,6.0,
80,Response Rates,12.0,0.0,0.0,
81,Tolerability,6.0,1.0,0.0,
82,Safety,44.0,6.0,9.0,
83,Efficacy,78.0,15.0,1.0,
84,Therapeutic Potential,29.0,0.0,0.0,
85,Clinical Evidence,10.0,3.0,2.0,
86,Immunoregulation,1.0,0.0,0.0,
87,Industry Outlook,6.0,1.0,1.0,
88,Shareholder Returns,24.0,2.0,7.0,
89,Investor Sentiment,21.0,3.0,8.0,
90,Market Penetration,8.0,1.0,2.0,
91,Subscriber Metrics,3.0,1.0,1.0,
92,Macro Environment,0.0,1.0,0.0,
93,Guidance,64.0,26.0,59.0,
94,Digital Strategy,23.0,0.0,0.0,
95,,0.0,0.0,0.0,573.0
96,Earnings Quality,4.0,1.0,0.0,
97,Digital,24.0,1.0,0.0,
98,Brand Strength,17.0,0.0,1.0,
99,Promotions,10.0,5.0,8.0,
100,Acquisitions,39.0,4.0,21.0,
101,Accounts,1.0,0.0,0.0,
102,Yields,1.0,0.0,0.0,
103,Opportunities,13.0,0.0,0.0,
104,Trade Policy,0.0,1.0,0.0,
105,Credit Risk,4.0,3.0,11.0,
106,Restructuring,9.0,1.0,4.0,
107,Asset Sales,5.0,0.0,0.0,
108,Buybacks,19.0,1.0,4.0,
109,Technology Investments,4.0,0.0,0.0,
110,Earnings Growth,75.0,9.0,7.0,
111,Return on Capital,3.0,1.0,0.0,
112,Liabilities,0.0,3.0,7.0,
113,Marketing,56.0,2.0,14.0,
114,Capital Expenditure,18.0,18.0,35.0,
115,Customer Engagement,81.0,2.0,2.0,
116,Capacity Utilization,2.0,0.0,0.0,
117,Pricing Strategy,9.0,2.0,4.0,
118,Processes,1.0,0.0,0.0,
119,Execution,32.0,3.0,24.0,
120,Execution Risk,0.0,0.0,1.0,
121,Customer Demand,12.0,3.0,7.0,
122,Brand Performance,1.0,0.0,0.0,
123,Intellectual Property,1.0,0.0,13.0,
124,Capacity,18.0,2.0,12.0,
125,Subscriber Growth,10.0,0.0,2.0,
126,Earnings Visibility,3.0,0.0,3.0,
127,Inflation,1.0,3.0,10.0,
128,Labor Challenges,0.0,0.0,2.0,
129,Management,148.0,29.0,41.0,
130,Digital Payments,1.0,0.0,0.0,
131,Currency Volatility,0.0,0.0,2.0,
132,Taxes,0.0,3.0,2.0,
133,Visibility,4.0,1.0,11.0,
134,Deal-Making,3.0,0.0,0.0,
135,Estimates,6.0,1.0,7.0,
136,Liquidity,31.0,10.0,8.0,
137,Assets,4.0,2.0,0.0,
138,Licensing,1.0,0.0,0.0,
139,Subscription Fees,1.0,0.0,0.0,
140,Transaction Fees,4.0,0.0,0.0,
141,Customer Relationships,19.0,0.0,1.0,
142,Traffic Growth,8.0,0.0,2.0,
143,Volatility,1.0,3.0,10.0,
144,Customer Experience,26.0,3.0,0.0,
145,Data Integration,3.0,0.0,0.0,
146,Personalization,2.0,0.0,0.0,
147,Market Demand,36.0,3.0,4.0,
148,E-commerce,13.0,3.0,4.0,
149,Impact Analysis,1.0,0.0,1.0,
150,Cannibalization,0.0,0.0,2.0,
151,Traffic Impact,0.0,0.0,2.0,
152,Sales Performance,7.0,0.0,16.0,
153,Credit Costs,0.0,1.0,4.0,
154,Productivity,14.0,1.0,0.0,
155,Employee Value,1.0,0.0,0.0,
156,Technology,184.0,6.0,4.0,
157,Forecast,1.0,4.0,3.0,
158,Supplier Relations,1.0,0.0,0.0,
159,Employee Satisfaction,5.0,0.0,0.0,
160,Engagement,14.0,0.0,1.0,
161,Monetization,4.0,0.0,2.0,
162,Digital Initiatives,4.0,0.0,0.0,
163,Traffic,32.0,3.0,14.0,
164,Refranchising,4.0,1.0,0.0,
165,Efficiency,65.0,2.0,1.0,
166,Synergies,18.0,0.0,1.0,
167,Market Presence,21.0,6.0,1.0,
168,Industry Exposure,0.0,1.0,0.0,
169,E-commerce Impact,0.0,3.0,0.0,
170,Valuation Metrics,1.0,2.0,2.0,
171,Acquisition,14.0,10.0,2.0,
172,Caution,0.0,0.0,9.0,
173,Vendor Dependency,0.0,0.0,3.0,
174,Outlook,5.0,2.0,9.0,
175,Customer Retention,11.0,2.0,0.0,
176,Return Profile,2.0,0.0,0.0,
177,Sales Recovery,4.0,0.0,0.0,
178,Global Unit Development,1.0,0.0,0.0,
179,Financial Discipline,1.0,0.0,1.0,
180,Customer Mobility,1.0,0.0,0.0,
181,Volume,15.0,5.0,12.0,
182,Volumes,0.0,1.0,4.0,
183,EBIT,1.0,1.0,2.0,
184,Credit,6.0,1.0,3.0,
185,Capital Markets,5.0,0.0,1.0,
186,Operating Leverage,6.0,1.0,3.0,
187,Churn,6.0,0.0,3.0,
188,Pipeline,12.0,1.0,2.0,
189,Manufacturing,5.0,0.0,5.0,
190,Distribution,3.0,1.0,0.0,
191,Taxation,3.0,2.0,0.0,
192,Customer Dependence,0.0,0.0,7.0,
193,Fees,5.0,5.0,9.0,
194,Investment,9.0,5.0,8.0,
195,Leverage,9.0,3.0,13.0,
196,Contract Exposure,1.0,0.0,0.0,
197,Contracts,2.0,0.0,0.0,
198,Consumer Engagement,3.0,0.0,0.0,
199,Bookings,4.0,1.0,5.0,
200,EBITDA,16.0,6.0,10.0,
201,Management Guidance,3.0,2.0,1.0,
202,ARPA,1.0,0.0,0.0,
203,Volume Growth,5.0,0.0,1.0,
204,Travel Volumes,1.0,2.0,1.0,
205,Cross-Border Travel,0.0,0.0,1.0,
206,Commodities,2.0,0.0,1.0,
207,Financial Structure,1.0,0.0,0.0,
208,Capex,4.0,4.0,4.0,
209,Subscriber Acquisition,1.0,0.0,0.0,
210,Subscriber Churn,0.0,0.0,1.0,
211,Capital Allocation,19.0,3.0,1.0,
212,Negotiation,0.0,1.0,0.0,
213,Geographic Performance,1.0,0.0,0.0,
214,Regulatory Validation,6.0,0.0,0.0,
215,Efficiency Gains,2.0,0.0,0.0,
216,Industry Interest,4.0,0.0,0.0,
217,Proprietary Programs,0.0,0.0,5.0,
218,Pipeline Development,2.0,0.0,5.0,
219,Loans,11.0,1.0,2.0,
220,Credit Losses,2.0,0.0,2.0,
221,Macro Conditions,1.0,0.0,2.0,
222,Home Lending,1.0,0.0,0.0,
223,Deposits,12.0,1.0,1.0,
224,Business Resilience,1.0,0.0,0.0,
225,Vaccination Impact,1.0,0.0,0.0,
226,Risk Assessment,0.0,1.0,0.0,
227,Safety and Efficacy,3.0,0.0,0.0,
228,Regulatory Approval,16.0,3.0,3.0,
229,Logistics,0.0,0.0,1.0,
230,Return on Assets,0.0,1.0,0.0,
231,Return on Tangible Common Equity,1.0,2.0,0.0,
232,Capital Ratio,6.0,2.0,2.0,
233,Loan Loss Provision,4.0,0.0,5.0,
234,Economic Indicators,1.0,0.0,0.0,
235,Allowance Coverage,0.0,1.0,0.0,
236,Uncertainty,0.0,0.0,3.0,
237,Resilience,2.0,0.0,0.0,
238,Currency Impact,2.0,0.0,11.0,
239,Health Concerns,0.0,0.0,1.0,
240,Cost Increases,0.0,0.0,2.0,
241,Probability of Success,2.0,0.0,0.0,
242,Financial Stability,5.0,3.0,5.0,
243,Funding,4.0,0.0,0.0,
244,Market Trends,13.0,6.0,3.0,
245,Competitive Positioning,22.0,0.0,1.0,
246,Competitive Advantage,16.0,0.0,1.0,
247,Business Fundamentals,4.0,0.0,2.0,
248,Exploration Technology,1.0,0.0,0.0,
249,Discovery Confirmation,0.0,1.0,0.0,
250,Reserves,3.0,5.0,2.0,
251,Mining Confidence,1.0,0.0,0.0,
252,Price,2.0,0.0,4.0,
253,Capital Structure,3.0,0.0,0.0,
254,Free Cash Flow,16.0,0.0,3.0,
255,Digital Capabilities,16.0,0.0,0.0,
256,Management Commentary,5.0,0.0,0.0,
257,Market Outlook,2.0,1.0,3.0,
258,Capital Efficiency,1.0,0.0,2.0,
259,Integration,9.0,1.0,5.0,
260,Workforce Management,0.0,0.0,1.0,
261,Operational Timing,0.0,1.0,1.0,
262,Milestones,0.0,1.0,0.0,
263,Relationships,4.0,0.0,0.0,
264,Business Model,7.0,1.0,0.0,
265,Deliveries,4.0,0.0,5.0,
266,Consumer Health,1.0,0.0,0.0,
267,Corporate Health,1.0,0.0,0.0,
268,Credit Quality,11.0,2.0,7.0,
269,Operational Risks,0.0,0.0,17.0,
270,Market Risks,0.0,1.0,11.0,
271,Regulatory Risks,1.0,1.0,20.0,
272,Macroeconomic Risks,0.0,0.0,1.0,
273,Growth Opportunities,16.0,0.0,0.0,
274,Incentives,5.0,3.0,3.0,
275,Pipeline Execution,1.0,0.0,0.0,
276,Management Strategy,3.0,3.0,1.0,
277,Investor Confidence,3.0,0.0,1.0,
278,Commercial Opportunity,1.0,0.0,0.0,
279,Research,17.0,1.0,0.0,
280,Advertiser Engagement,4.0,0.0,1.0,
281,Execution Risks,0.0,0.0,5.0,
282,Operating Income,10.0,3.0,3.0,
283,Market Recovery,4.0,2.0,1.0,
284,Product Contribution,2.0,1.0,0.0,
285,Retail Environment,1.0,0.0,0.0,
286,Sales Estimates,1.0,0.0,3.0,
287,EPS Estimates,1.0,0.0,0.0,
288,Ownership,10.0,0.0,0.0,
289,Advertising Spend,0.0,1.0,0.0,
290,Bookings Mix,0.0,1.0,0.0,
291,Ad Price Inflation,0.0,1.0,0.0,
292,Economics,0.0,0.0,1.0,
293,Management Messaging,1.0,0.0,0.0,
294,Core Business,3.0,0.0,0.0,
295,Product Acceptance,4.0,0.0,0.0,
296,Challenges,0.0,0.0,12.0,
297,Volume Trends,2.0,1.0,0.0,
298,Operational Change,2.0,0.0,0.0,
299,Strategic Change,2.0,0.0,0.0,
300,Cost Synergies,1.0,0.0,0.0,
301,Value Creation,9.0,0.0,0.0,
302,Healthcare,2.0,0.0,1.0,
303,Beauty,0.0,0.0,1.0,
304,Brand Equity,5.0,0.0,0.0,
305,Product Pipeline,4.0,0.0,0.0,
306,Input Costs,0.0,0.0,4.0,
307,FX Headwinds,0.0,0.0,1.0,
308,EPS Growth,0.0,0.0,1.0,
309,COVID Exposure,0.0,0.0,1.0,
310,Catalysts,4.0,0.0,2.0,
311,Value Unlocking,1.0,0.0,0.0,
312,Divestitures,1.0,0.0,2.0,
313,Governance,2.0,0.0,4.0,
314,Accountability,1.0,0.0,2.0,
315,Regulatory Action,1.0,0.0,0.0,
316,Risk Management,8.0,2.0,2.0,
317,Loan Loss Reserves,2.0,1.0,4.0,
318,Returns,4.0,0.0,3.0,
319,Financial Targets,0.0,0.0,2.0,
320,Global Complexity,0.0,0.0,1.0,
321,Sales Channel Mix,1.0,0.0,0.0,
322,Housing Fundamentals,1.0,0.0,0.0,
323,Home Prices,2.0,0.0,0.0,
324,Supply,4.0,1.0,5.0,
325,First-time Buyers,1.0,0.0,0.0,
326,Aging Housing Stock,1.0,0.0,0.0,
327,Tax Reform,0.0,2.0,0.0,
328,Home Improvement Spending,1.0,0.0,0.0,
329,Stores,3.0,0.0,1.0,
330,Security Risks,0.0,0.0,4.0,
331,Promotional Spend,0.0,0.0,1.0,
332,Subscribers,0.0,0.0,1.0,
333,Accuracy,0.0,1.0,0.0,
334,Investment Banking,2.0,1.0,1.0,
335,AI Utilization,1.0,0.0,0.0,
336,User Experience,6.0,0.0,4.0,
337,Return On Assets,2.0,2.0,1.0,
338,Interest Rates,1.0,1.0,8.0,
339,Loan Growth,6.0,0.0,1.0,
340,Consumer Loans,2.0,2.0,0.0,
341,Mortgage Applications,1.0,0.0,0.0,
342,Card Balances,1.0,0.0,0.0,
343,Residential Mortgages,1.0,0.0,0.0,
344,Small Business Growth,1.0,0.0,0.0,
345,Commercial Loans,2.0,0.0,0.0,
346,Compensation,4.0,1.0,3.0,
347,Allowance,0.0,0.0,1.0,
348,CET1 Ratio,0.0,0.0,1.0,
349,Asset Sensitivity,1.0,2.0,0.0,
350,Tax Rate,6.0,11.0,8.0,
351,Tax Benefits,3.0,0.0,1.0,
352,NCO Ratio,0.0,1.0,0.0,
353,Reserve Ratio,0.0,0.0,1.0,
354,Cost of Deposits,1.0,0.0,0.0,
355,Branches,0.0,0.0,1.0,
356,Delinquencies,0.0,0.0,3.0,
357,Net Income,1.0,1.0,2.0,
358,Client Balances,1.0,0.0,0.0,
359,Household Growth,1.0,0.0,0.0,
360,Mobile Usage,1.0,0.0,0.0,
361,Efficiency Ratio,0.0,0.0,1.0,
362,User Growth,3.0,0.0,4.0,
363,Average Ticket,0.0,1.0,0.0,
364,Ancillary Revenue,1.0,0.0,0.0,
365,Employee Compensation,1.0,0.0,1.0,
366,Installed Base,0.0,0.0,1.0,
367,Market Development,0.0,0.0,3.0,
368,Product Delays,0.0,0.0,2.0,
369,Software Capabilities,5.0,0.0,0.0,
370,Losses,1.0,0.0,6.0,
371,Releases,1.0,0.0,0.0,
372,Loan Loss Reserve,2.0,0.0,6.0,
373,Net Interest Margin,1.0,0.0,4.0,
374,Asset Quality,9.0,0.0,5.0,
375,Capital Optimization,3.0,1.0,0.0,
376,Economic Outlook,0.0,0.0,2.0,
377,Trading Results,1.0,0.0,0.0,
378,Hedging Gains,1.0,0.0,0.0,
379,Spending Trends,0.0,0.0,1.0,
380,NCL Rates,0.0,1.0,1.0,
381,Economic Environment,0.0,0.0,1.0,
382,Risk Exposure,1.0,0.0,0.0,
383,Loan Portfolios,2.0,0.0,0.0,
384,Customer Service,6.0,0.0,2.0,
385,Trading,5.0,1.0,0.0,
386,Client Activity,1.0,0.0,0.0,
387,Corporate Lending,0.0,0.0,1.0,
388,Exploration,9.0,1.0,1.0,
389,Advertising,4.0,1.0,4.0,
390,Macroeconomic Conditions,0.0,0.0,9.0,
391,International Operations,1.0,0.0,1.0,
392,Sales Forecast,0.0,0.0,3.0,
393,Flexibility,4.0,0.0,0.0,
394,Diversification,3.0,0.0,0.0,
395,Growth Momentum,1.0,0.0,0.0,
396,Historical Performance,1.0,0.0,1.0,
397,COVID Impact,0.0,1.0,2.0,
398,Pharmaceuticals,1.0,0.0,0.0,
399,Legal Risks,5.0,3.0,16.0,
400,Imports,0.0,0.0,1.0,
401,Labor Dispute,0.0,0.0,1.0,
402,Network Reach,1.0,0.0,0.0,
403,Operational Efficiency,16.0,1.0,2.0,
404,Operational Flexibility,1.0,0.0,0.0,
405,Traffic Management,1.0,0.0,0.0,
406,Utilization,1.0,2.0,0.0,
407,Capital Spending,1.0,0.0,0.0,
408,Dividends,6.0,2.0,1.0,
409,Infrastructure,2.0,0.0,1.0,
410,Financial Strength,7.0,0.0,0.0,
411,Earnings Momentum,1.0,0.0,1.0,
412,Operational Talent,1.0,0.0,0.0,
413,Services,1.0,1.0,0.0,
414,Prospects,0.0,0.0,1.0,
415,Saturation,0.0,0.0,1.0,
416,Brand Perception,0.0,0.0,1.0,
417,Strategy,4.0,2.0,1.0,
418,ROI,0.0,0.0,1.0,
419,Value Proposition,5.0,1.0,0.0,
420,Transaction Costs,1.0,0.0,0.0,
421,Network Strategy,1.0,0.0,0.0,
422,Market Reaction,3.0,0.0,2.0,
423,Consumer Behavior,16.0,10.0,8.0,
424,Customer Behavior,2.0,1.0,2.0,
425,Shareholder Value,4.0,0.0,2.0,
426,Product Development,31.0,3.0,4.0,
427,Digital Marketing,1.0,0.0,0.0,
428,Adoption,4.0,0.0,4.0,
429,Strategic Alternatives,1.0,0.0,0.0,
430,Switching Costs,0.0,0.0,1.0,
431,Acquisition and Retention,0.0,0.0,1.0,
432,Brand Name,0.0,0.0,1.0,
433,Mobile Effectiveness,0.0,0.0,1.0,
434,International Reception,0.0,0.0,1.0,
435,Software Errors,0.0,0.0,1.0,
436,Sales Dependence,0.0,0.0,1.0,
437,Product Announcements,1.0,0.0,0.0,
438,Commodity Impact,0.0,1.0,0.0,
439,Tariff Exclusions,1.0,0.0,0.0,
440,Purchase Protection,1.0,0.0,0.0,
441,Contingency Plans,0.0,1.0,0.0,
442,GMS,0.0,1.0,0.0,
443,Loan Portfolio,2.0,0.0,0.0,
444,Customer Base,4.0,0.0,0.0,
445,Customer Loyalty,8.0,0.0,0.0,
446,Customer Satisfaction,5.0,0.0,0.0,
447,Branch Investment,1.0,0.0,0.0,
448,Service Efficiency,1.0,0.0,0.0,
449,Client Focus,1.0,0.0,0.0,
450,Digital Integration,1.0,0.0,0.0,
451,Operational Excellence,2.0,0.0,0.0,
452,Income Generation,1.0,0.0,0.0,
453,Oversight,0.0,0.0,1.0,
454,Transformation Program,1.0,0.0,0.0,
455,Leadership Accountability,1.0,0.0,0.0,
456,Compensation Philosophy,0.0,0.0,1.0,
457,Transformation,4.0,0.0,0.0,
458,Provisions,0.0,0.0,1.0,
459,Headwinds,0.0,0.0,6.0,
460,Lifecycle Management,0.0,0.0,1.0,
461,Growth Strategies,0.0,0.0,1.0,
462,Life Cycle Management,1.0,0.0,0.0,
463,Demographics,0.0,1.0,1.0,
464,Study Characteristics,0.0,1.0,0.0,
465,Safety Concerns,0.0,0.0,1.0,
466,Approval Risks,0.0,0.0,2.0,
467,Investment Opportunity,1.0,0.0,0.0,
468,Regulatory Issues,5.0,4.0,6.0,
469,Net Interest Income,9.0,3.0,5.0,
470,Securities,0.0,0.0,1.0,
471,Reserve Build,0.0,0.0,1.0,
472,Securities Losses,0.0,0.0,1.0,
473,FICC,1.0,0.0,0.0,
474,Equities,0.0,0.0,1.0,
475,Income,1.0,1.0,1.0,
476,Nonperforming Assets,0.0,0.0,1.0,
477,Charge-offs,0.0,0.0,1.0,
478,Loan Modifications,0.0,1.0,0.0,
479,Customer Assistance,1.0,1.0,1.0,
480,Loan Performance,3.0,1.0,5.0,
481,Commitments,0.0,2.0,0.0,
482,Operational Readiness,2.0,1.0,0.0,
483,Market Participation,1.0,0.0,0.0,
484,Regulatory Engagement,1.0,0.0,0.0,
485,Capital Requirements,4.0,2.0,1.0,
486,Credit Protection,1.0,0.0,0.0,
487,Market Exposure,0.0,1.0,2.0,
488,Collateral Management,0.0,1.0,1.0,
489,Tax Impact,1.0,0.0,3.0,
490,Book Value Protection,0.0,2.0,0.0,
491,Exposure,0.0,2.0,0.0,
492,Market Risk,0.0,2.0,0.0,
493,Financing,0.0,2.0,0.0,
494,Bond Quality,0.0,2.0,0.0,
495,Trust Management,0.0,1.0,0.0,
496,Loss Exposure,0.0,1.0,1.0,
497,Financial Exposure,0.0,0.0,1.0,
498,Accounting Impact,0.0,1.0,0.0,
499,Administrative Burden,1.0,0.0,0.0,
500,Consumer Resilience,1.0,0.0,0.0,
501,Tax Policy,0.0,0.0,1.0,
502,Risk/Reward,2.0,0.0,1.0,
503,Recovery,5.0,0.0,5.0,
504,Air Travel,1.0,0.0,0.0,
505,EBITDA Growth,2.0,0.0,0.0,
506,Experiences and Dining,0.0,0.0,1.0,
507,Brand Marketing,0.0,0.0,1.0,
508,Growth Projects,0.0,1.0,0.0,
509,Operational Stability,2.0,0.0,0.0,
510,Transaction Complexity,0.0,0.0,1.0,
511,Patient Population,0.0,1.0,0.0,
512,Survival Data,1.0,0.0,0.0,
513,Patient Outcomes,7.0,3.0,0.0,
514,Clinical Development,14.0,2.0,1.0,
515,Timelines,0.0,1.0,0.0,
516,Ecosystem Positioning,1.0,0.0,0.0,
517,Intermediaries,1.0,0.0,0.0,
518,Bank Relationships,1.0,0.0,0.0,
519,Tech Relationships,1.0,0.0,0.0,
520,Operational Focus,0.0,0.0,1.0,
521,Repeat Buyers,0.0,0.0,1.0,
522,Corporate Governance,1.0,0.0,1.0,
523,Mission Statement,1.0,0.0,0.0,
524,Buyer Reactivation,1.0,0.0,0.0,
525,Shipping Labels,1.0,0.0,0.0,
526,Conversion,2.0,0.0,1.0,
527,Conversion Rates,0.0,1.0,0.0,
528,Sales Tax Impact,0.0,0.0,1.0,
529,Value,4.0,0.0,2.0,
530,Investment Risks,0.0,0.0,2.0,
531,Sales and Marketing,1.0,0.0,2.0,
532,Product Appeal,1.0,0.0,0.0,
533,Supply Capability,0.0,1.0,0.0,
534,Raw Materials,0.0,0.0,3.0,
535,Sales Risk,0.0,0.0,1.0,
536,Membership,5.0,1.0,0.0,
537,Renewal Rates,0.0,1.0,0.0,
538,Wage Impact,0.0,0.0,1.0,
539,Value Offering,0.0,0.0,1.0,
540,Operational Complexity,0.0,0.0,2.0,
541,Options,0.0,1.0,1.0,
542,Margin Recovery,1.0,1.0,0.0,
543,Project Reengineering,0.0,1.0,0.0,
544,Mine Planning,1.0,0.0,0.0,
545,Resources,2.0,0.0,0.0,
546,Labor Outlook,0.0,1.0,0.0,
547,Capital Deployment,0.0,1.0,0.0,
548,Debt Levels,0.0,1.0,2.0,
549,International Margins,0.0,0.0,1.0,
550,Growth Potential,4.0,5.0,0.0,
551,Technology Adoption,0.0,0.0,1.0,
552,Geopolitical Risks,0.0,6.0,4.0,
553,Brand Recognition,1.0,0.0,0.0,
554,Product Adoption,1.0,0.0,1.0,
555,Share Repurchase,4.0,0.0,0.0,
556,Consumer Connection,2.0,0.0,0.0,
557,Capital,5.0,2.0,5.0,
558,Litigation,4.0,1.0,3.0,
559,Capital Ratios,1.0,1.0,2.0,
560,Legal Outcome,1.0,0.0,0.0,
561,Financial Recovery,1.0,0.0,0.0,
562,Interest Rate Sensitivity,0.0,1.0,1.0,
563,Trading Contributions,0.0,1.0,0.0,
564,Currency Exposure,0.0,0.0,1.0,
565,Capital Build,1.0,0.0,0.0,
566,Short Interest,0.0,2.0,0.0,
567,Inventory Risk,1.0,0.0,6.0,
568,Supply Risks,0.0,0.0,6.0,
569,Expert Opinions,0.0,5.0,3.0,
570,Currency Risk,0.0,6.0,11.0,
571,Digital Sales,2.0,0.0,0.0,
572,Store Traffic,1.0,0.0,0.0,
573,Consumer Spending,3.0,1.0,1.0,
574,Credit Trends,1.0,0.0,0.0,
575,Financial Positioning,2.0,0.0,2.0,
576,Operational Issues,0.0,0.0,10.0,
577,Economic Risks,0.0,0.0,3.0,
578,Currency Risks,0.0,0.0,2.0,
579,Operating Expenses,3.0,4.0,1.0,
580,Data Privacy,1.0,0.0,1.0,
581,Compliance,1.0,0.0,2.0,
582,Labor Pressure,1.0,0.0,0.0,
583,Operational Metrics,1.0,0.0,1.0,
584,Shipping Penetration,0.0,1.0,0.0,
585,Credit Provisions,1.0,0.0,0.0,
586,Financial Pressure,0.0,0.0,1.0,
587,Earnings Risk,0.0,0.0,1.0,
588,Stock Performance,4.0,0.0,0.0,
589,Business Improvement,1.0,0.0,0.0,
590,Store Productivity,1.0,0.0,0.0,
591,Cost Savings,3.0,0.0,0.0,
592,Consumer Trends,2.0,0.0,2.0,
593,Operational Risk,0.0,0.0,1.0,
594,FX Impact,0.0,0.0,1.0,
595,Mobile Revenue,0.0,0.0,3.0,
596,Financials,3.0,8.0,2.0,
597,Network State,1.0,0.0,0.0,
598,Competitive Landscape,1.0,1.0,0.0,
599,5G Launch,1.0,0.0,0.0,
600,Advertising Trends,0.0,0.0,2.0,
601,Content Pipeline,2.0,0.0,0.0,
602,Management Confidence,4.0,0.0,0.0,
603,Network Position,1.0,0.0,0.0,
604,Market Dynamics,2.0,0.0,1.0,
605,Dependence,0.0,1.0,12.0,
606,Reputation,3.0,0.0,5.0,
607,Trustworthiness,0.0,0.0,1.0,
608,Advertising Practices,0.0,0.0,1.0,
609,Legal Issues,0.0,1.0,9.0,
610,Launch Milestones,1.0,0.0,0.0,
611,Sales Royalties,1.0,0.0,0.0,
612,Market Competition,1.0,0.0,0.0,
613,Clinical Trials,6.0,1.0,2.0,
614,Regulatory Pathway,1.0,0.0,0.0,
615,Supply Obligations,0.0,1.0,0.0,
616,Software Differentiation,1.0,0.0,0.0,
617,Workforce,0.0,1.0,2.0,
618,Shipping Costs,0.0,0.0,2.0,
619,Investment Cycle,0.0,0.0,1.0,
620,Media Growth,0.0,0.0,1.0,
621,Tax,6.0,3.0,2.0,
622,Earnings Catalysts,5.0,0.0,0.0,
623,Yield Improvement,1.0,0.0,0.0,
624,Household Penetration,2.0,0.0,0.0,
625,Delivery,2.0,0.0,1.0,
626,Economic Forecasts,0.0,0.0,1.0,
627,Debt Underwriting,1.0,0.0,0.0,
628,Capital Position,3.0,0.0,0.0,
629,Trading Performance,3.0,0.0,0.0,
630,Credit Risks,0.0,0.0,1.0,
631,Cost of Capital,1.0,0.0,0.0,
632,Dependency,0.0,0.0,6.0,
633,Promotional Discipline,1.0,0.0,0.0,
634,Inventory Levels,0.0,0.0,1.0,
635,Retail Performance,0.0,0.0,1.0,
636,Earnings Miss,0.0,0.0,1.0,
637,Pricing Pressure,0.0,0.0,3.0,
638,Sourcing Exposure,0.0,1.0,1.0,
639,Market Performance,3.0,1.0,2.0,
640,Promotional Activity,3.0,2.0,2.0,
641,Margin Pressure,0.0,0.0,1.0,
642,Earnings Revision Risk,0.0,0.0,1.0,
643,Tariff Impact,0.0,1.0,0.0,
644,Pipeline Assets,1.0,0.0,0.0,
645,Sales Outlook,0.0,1.0,0.0,
646,Earnings Outlook,0.0,1.0,2.0,
647,Business Development,0.0,1.0,1.0,
648,Operating Losses,0.0,0.0,3.0,
649,Management Caution,0.0,0.0,1.0,
650,Capital Management,0.0,2.0,3.0,
651,Core Costs,1.0,0.0,0.0,
652,Equity Losses,0.0,0.0,1.0,
653,Securities Gains,2.0,0.0,0.0,
654,Expectations,2.0,0.0,4.0,
655,Import Activity,1.0,0.0,0.0,
656,Capacity Additions,2.0,0.0,0.0,
657,Industry Review,0.0,1.0,0.0,
658,Imports Evaluation,0.0,1.0,0.0,
659,Rebates & Incentives,1.0,0.0,0.0,
660,Yield,2.0,0.0,0.0,
661,Automation,2.0,0.0,0.0,
662,Regulatory Submissions,1.0,0.0,0.0,
663,Patient Enrollment,2.0,0.0,0.0,
664,Pharmacodynamics,1.0,0.0,0.0,
665,Asset Base,1.0,0.0,0.0,
666,Drilling Results,0.0,1.0,0.0,
667,Oil Cuts,2.0,0.0,0.0,
668,Oil Leverage,1.0,0.0,0.0,
669,Development Options,1.0,0.0,0.0,
670,Employee Retention,3.0,0.0,0.0,
671,Incentive Compensation,1.0,0.0,0.0,
672,Executive Pay,1.0,0.0,0.0,
673,Credit Activity,0.0,0.0,1.0,
674,Credit Loss Provisions,0.0,0.0,1.0,
675,Loyalty Program,3.0,0.0,0.0,
676,Data Collection,1.0,0.0,0.0,
677,Cash Efficiency,1.0,0.0,0.0,
678,Reimbursement,1.0,0.0,0.0,
679,Patient Monitoring,1.0,0.0,0.0,
680,Clinical Intervention,1.0,0.0,0.0,
681,Trial Results,2.0,2.0,0.0,
682,Operating Risk,0.0,0.0,3.0,
683,Cash Generation,3.0,0.0,0.0,
684,Return on Invested Capital,2.0,0.0,0.0,
685,Shipping Losses,0.0,1.0,0.0,
686,Digital Engagement,7.0,0.0,0.0,
687,Food Sales,1.0,0.0,0.0,
688,Same-store Sales,0.0,1.0,0.0,
689,Capacity Issues,0.0,0.0,1.0,
690,Transaction Trends,0.0,1.0,0.0,
691,Operational Improvements,1.0,0.0,0.0,
692,Travel Demand,4.0,0.0,2.0,
693,Digitalization,1.0,0.0,0.0,
694,Underwriting,1.0,0.0,0.0,
695,Consumer Protection,1.0,0.0,0.0,
696,Partnerships and Collaborations,2.0,0.0,0.0,
697,Digital Assets,1.0,0.0,0.0,
698,Consumer Protections,1.0,0.0,0.0,
699,Sentiment,1.0,1.0,0.0,
700,Subscriptions,1.0,0.0,0.0,
701,Prices,0.0,0.0,1.0,
702,Product Launch,4.0,1.0,0.0,
703,Stock Buyback,1.0,0.0,0.0,
704,Market Impact,0.0,1.0,1.0,
705,Channel Development,1.0,0.0,1.0,
706,Share Repurchases,0.0,0.0,1.0,
707,Retail Outlook,1.0,0.0,0.0,
708,Earnings Per Share,1.0,0.0,2.0,
709,Global Growth,1.0,0.0,1.0,
710,Customer Resilience,1.0,0.0,0.0,
711,Executional Risk,0.0,0.0,2.0,
712,Paid Clicks,1.0,0.0,0.0,
713,CPC,0.0,0.0,1.0,
714,Loan Accommodations,1.0,0.0,0.0,
715,Consumer Payments,1.0,0.0,0.0,
716,Legal Expenses,0.0,0.0,2.0,
717,Unrealized Gains,1.0,0.0,0.0,
718,Operational Continuity,1.0,0.0,0.0,
719,Market Response,1.0,0.0,0.0,
720,Employee Safety,1.0,0.0,0.0,
721,Liquidity Support,1.0,0.0,0.0,
722,Government Programs,1.0,0.0,0.0,
723,Loan Deferrals,1.0,0.0,0.0,
724,Repurchases,0.0,0.0,1.0,
725,Criticized Assets,0.0,0.0,1.0,
726,Consumer Impact,0.0,0.0,1.0,
727,Pandemic Effects,0.0,0.0,1.0,
728,Income Impact,0.0,0.0,1.0,
729,Regulatory,3.0,2.0,0.0,
730,Capex Guidance,0.0,1.0,0.0,
731,Production Guidance,1.0,1.0,1.0,
732,Production Risk,0.0,0.0,1.0,
733,Exploration Success,1.0,0.0,0.0,
734,Raw Material Costs,1.0,0.0,0.0,
735,Negotiations,0.0,1.0,1.0,
736,Debt,3.0,8.0,31.0,
737,Supply Issues,0.0,0.0,2.0,
738,Data Readout,1.0,0.0,0.0,
739,Clinical Studies,1.0,0.0,0.0,
740,Litigation Risks,0.0,0.0,3.0,
741,Complexity,0.0,1.0,2.0,
742,Capital Needs,0.0,0.0,4.0,
743,Credit Outlook,0.0,1.0,0.0,
744,Market Opportunities,11.0,1.0,0.0,
745,Operating Margin,5.0,3.0,1.0,
746,Transparency,1.0,0.0,1.0,
747,Experience,2.0,0.0,0.0,
748,Transition,1.0,2.0,1.0,
749,Orders,3.0,0.0,0.0,
750,Revenue Growth,7.0,0.0,0.0,
751,Opportunity Cost,0.0,0.0,1.0,
752,Confidence,4.0,0.0,1.0,
753,Wage Environment,1.0,0.0,0.0,
754,Digital Investments,2.0,0.0,0.0,
755,Clinical Utility,2.0,0.0,0.0,
756,Phase 3 Trial,1.0,0.0,0.0,
757,Survival,1.0,0.0,0.0,
758,Phase 1 Study,1.0,1.0,0.0,
759,Pipeline Progress,2.0,0.0,0.0,
760,Cytokine Manipulation,1.0,0.0,0.0,
761,Polymer Conjugation,1.0,0.0,0.0,
762,Corporate Efficiency,3.0,0.0,0.0,
763,Probability Assessment,0.0,3.0,0.0,
764,Treatment Options,0.0,2.0,0.0,
765,Durability of Response,0.0,3.0,0.0,
766,Primary Endpoint,0.0,3.0,0.0,
767,Licensure Risks,0.0,0.0,4.0,
768,Investor Perception,0.0,0.0,4.0,
769,Shareholder Dilution,0.0,0.0,4.0,
770,Trends,1.0,0.0,2.0,
771,Sales Impact,0.0,1.0,1.0,
772,Digital Banking,4.0,0.0,0.0,
773,Performance Metrics,1.0,0.0,0.0,
774,ASP,0.0,0.0,1.0,
775,Capital Investment,0.0,0.0,1.0,
776,Security,1.0,0.0,2.0,
777,Strategic Positioning,2.0,0.0,0.0,
778,Advertising Revenue,0.0,0.0,1.0,
779,Accounting,0.0,1.0,0.0,
780,Competitive Advantages,4.0,0.0,0.0,
781,Brand Fixability,1.0,0.0,0.0,
782,Top-Line Growth,2.0,0.0,0.0,
783,Brand Experience,2.0,0.0,0.0,
784,Global Growth Potential,1.0,0.0,0.0,
785,DTC Growth,1.0,0.0,0.0,
786,Operational Strategy,1.0,0.0,0.0,
787,Expansion Strategy,1.0,0.0,0.0,
788,Product Assortments,1.0,0.0,0.0,
789,Product Strategy,4.0,0.0,0.0,
790,Omni-channel Initiatives,1.0,0.0,0.0,
791,Brand Loyalty,2.0,0.0,0.0,
792,Product Demand,2.0,0.0,0.0,
793,Pricing Power,4.0,0.0,1.0,
794,Tax Expenses,0.0,0.0,1.0,
795,Coverage Expansion,2.0,0.0,0.0,
796,Clinical Outcomes,1.0,0.0,1.0,
797,Lymphocyte Stimulation,1.0,0.0,0.0,
798,Proprietary Opportunities,3.0,0.0,0.0,
799,Technological Advancements,3.0,0.0,0.0,
800,Value Generation,2.0,0.0,0.0,
801,Trial Outcomes,1.0,0.0,1.0,
802,Development Risks,0.0,0.0,3.0,
803,Operational Performance,6.0,1.0,3.0,
804,Equity,2.0,1.0,0.0,
805,Organizational Changes,2.0,0.0,0.0,
806,Profit Margins,1.0,0.0,1.0,
807,Customer Interest,1.0,0.0,0.0,
808,Hiring,2.0,0.0,0.0,
809,Analytics,1.0,0.0,0.0,
810,Service,1.0,0.0,0.0,
811,Sales Strategy,1.0,1.0,0.0,
812,Vendor Selection,1.0,0.0,0.0,
813,Access,0.0,0.0,1.0,
814,Product Quality,3.0,1.0,8.0,
815,Stability,0.0,0.0,1.0,
816,Financial Position,5.0,1.0,3.0,
817,Sales Volatility,0.0,0.0,1.0,
818,Mobile,1.0,0.0,0.0,
819,Payments,1.0,0.0,0.0,
820,Subscriber Success,1.0,0.0,0.0,
821,Network Capacity,1.0,0.0,0.0,
822,Management Estimates,1.0,0.0,0.0,
823,Inflation Impact,0.0,1.0,0.0,
824,Employee Investment,1.0,0.0,0.0,
825,Housing Market,2.0,0.0,0.0,
826,Legal Exposure,0.0,1.0,0.0,
827,Savings,3.0,0.0,0.0,
828,Upside Potential,2.0,0.0,0.0,
829,Labor,0.0,1.0,3.0,
830,Validation,3.0,0.0,0.0,
831,Contract Manufacturing,1.0,0.0,0.0,
832,Engineering Services,1.0,0.0,0.0,
833,Service Metrics,1.0,0.0,0.0,
834,Volume Data,0.0,1.0,0.0,
835,Profitability Clarity,0.0,0.0,1.0,
836,Tax Liability,1.0,0.0,1.0,
837,Credit Participation,1.0,0.0,0.0,
838,Collection Rates,0.0,0.0,1.0,
839,Network Performance,4.0,0.0,1.0,
840,Spectrum,0.0,0.0,2.0,
841,Spectrum Acquisition,1.0,0.0,1.0,
842,Network,1.0,0.0,0.0,
843,Auction Strategy,1.0,0.0,0.0,
844,Spectrum Holdings,1.0,0.0,0.0,
845,Coverage,0.0,0.0,1.0,
846,Availability,0.0,0.0,1.0,
847,Speed,1.0,0.0,0.0,
848,Business Potential,1.0,0.0,0.0,
849,Warranty,1.0,0.0,0.0,
850,Approval,2.0,0.0,0.0,
851,Expansion,3.0,0.0,1.0,
852,Development,1.0,2.0,2.0,
853,Omni-channel,1.0,0.0,0.0,
854,Obligations,0.0,0.0,1.0,
855,Transactions,1.0,1.0,1.0,
856,Core Performance,1.0,0.0,0.0,
857,Core Comps,1.0,0.0,0.0,
858,Upside Risks,2.0,0.0,0.0,
859,Downside Risks,0.0,0.0,6.0,
860,Transformation Duration,0.0,0.0,1.0,
861,Acquisition Strategy,2.0,0.0,0.0,
862,Adjusted Expenses,1.0,0.0,0.0,
863,Gains,2.0,0.0,0.0,
864,Non-performing Assets,1.0,0.0,0.0,
865,Reserve Management,1.0,0.0,1.0,
866,Opex/Capex Reduction,1.0,0.0,0.0,
867,Curtailments,0.0,1.0,0.0,
868,Rig Count,2.0,0.0,2.0,
869,Operational Changes,0.0,0.0,2.0,
870,Prime Membership,1.0,0.0,0.0,
871,Conversion Rate,1.0,0.0,0.0,
872,R&D,2.0,1.0,0.0,
873,International Presence,1.0,0.0,0.0,
874,Investment Challenges,0.0,0.0,2.0,
875,Growth Risks,0.0,0.0,2.0,
876,Dividend Pressure,0.0,0.0,1.0,
877,Investment Plans,1.0,0.0,0.0,
878,Digital Infrastructure,1.0,0.0,0.0,
879,Strategic Direction,2.0,0.0,1.0,
880,Culture,1.0,0.0,1.0,
881,Adaptability,1.0,0.0,0.0,
882,Data Assets,1.0,1.0,0.0,
883,CFO Transition,0.0,0.0,1.0,
884,Vendor Support,2.0,0.0,0.0,
885,Earnings Potential,1.0,0.0,0.0,
886,Customer Reception,1.0,0.0,0.0,
887,Sourcing,2.0,0.0,0.0,
888,Wages,2.0,0.0,1.0,
889,Category Mix,0.0,0.0,1.0,
890,Occupancy,0.0,0.0,1.0,
891,Real Estate,2.0,0.0,0.0,
892,Content Quality,0.0,0.0,3.0,
893,Perception Risk,0.0,0.0,1.0,
894,Enrollment,1.0,0.0,0.0,
895,Delays,0.0,0.0,1.0,
896,Digital Advertising,1.0,0.0,0.0,
897,Consumer Activity,1.0,0.0,0.0,
898,Traffic Costs,0.0,0.0,1.0,
899,Patient Demographics,1.0,0.0,0.0,
900,Collective Efforts,1.0,0.0,0.0,
901,Biomarkers,1.0,0.0,0.0,
902,Potential,1.0,1.0,0.0,
903,Security Issues,0.0,0.0,2.0,
904,Freight Demand,0.0,0.0,1.0,
905,Integration Challenges,0.0,0.0,1.0,
906,Profit Improvement,1.0,0.0,0.0,
907,EPS Expectations,0.0,1.0,0.0,
908,Rig Additions,1.0,0.0,0.0,
909,Shopping Patterns,0.0,1.0,0.0,
910,Price Increases,0.0,0.0,1.0,
911,Testing Strategy,0.0,1.0,0.0,
912,E-commerce Solution,1.0,0.0,0.0,
913,Cost Optimization,1.0,0.0,0.0,
914,Inventory Visibility,1.0,0.0,0.0,
915,Wholesale Volumes,0.0,0.0,1.0,
916,Earnings Before Interest and Taxes,0.0,1.0,0.0,
917,Transaction Revenue,1.0,0.0,0.0,
918,Marketing Services,1.0,0.0,0.0,
919,Seasonality,0.0,2.0,0.0,
920,Data Utilization,3.0,0.0,0.0,
921,Service Improvement,2.0,0.0,0.0,
922,Cost Pressure,0.0,0.0,1.0,
923,Investment Needs,0.0,0.0,1.0,
924,Transportation Costs,1.0,0.0,1.0,
925,Market Competitiveness,0.0,0.0,1.0,
926,Energy Impact,0.0,0.0,1.0,
927,Tax Guidance,0.0,0.0,1.0,
928,Wage Inflation,1.0,0.0,0.0,
929,Store Performance,1.0,0.0,0.0,
930,International Expansion,4.0,1.0,0.0,
931,Volume Leadership,1.0,0.0,0.0,
932,Fuel Costs,0.0,0.0,2.0,
933,Intermodal Conversions,1.0,0.0,0.0,
934,Network Balance,0.0,0.0,1.0,
935,Equipment Shortages,0.0,0.0,1.0,
936,Technology Enhancements,1.0,0.0,0.0,
937,Network Operations,0.0,0.0,1.0,
938,Equipment,0.0,0.0,1.0,
939,Digital Workforce,1.0,0.0,0.0,
940,Return On Invested Capital,3.0,0.0,0.0,
941,Return On Tangible Common Equity,0.0,2.0,2.0,
942,Loan Quality,1.0,1.0,1.0,
943,Client Engagement,3.0,0.0,0.0,
944,Transaction Volumes,1.0,0.0,0.0,
945,Loss,0.0,0.0,1.0,
946,Capital Impact,0.0,0.0,1.0,
947,Insurance,1.0,0.0,0.0,
948,Customer Incentives,1.0,0.0,0.0,
949,Consumer Position,1.0,0.0,0.0,
950,Consumer Strength,2.0,0.0,0.0,
951,Market Integration,1.0,0.0,0.0,
952,Technology Utilization,1.0,0.0,0.0,
953,Referrals,1.0,0.0,0.0,
954,Growth Strategy,1.0,0.0,0.0,
955,Corporate Citizenship,1.0,0.0,0.0,
956,Ecommerce,1.0,0.0,0.0,
957,Dividend Yield,1.0,0.0,0.0,
958,Commodity Costs,1.0,0.0,1.0,
959,Integration Risks,0.0,0.0,2.0,
960,Cultural Fit,0.0,0.0,2.0,
961,Management Commitment,0.0,0.0,2.0,
962,Workflow Alterations,0.0,0.0,2.0,
963,Equity Management,1.0,0.0,0.0,
964,Dilution,1.0,0.0,2.0,
965,Deleveraging,1.0,0.0,0.0,
966,Market Environment,1.0,0.0,0.0,
967,Turnaround Potential,1.0,0.0,0.0,
968,Resegmentation,0.0,1.0,0.0,
969,Commitment,1.0,0.0,0.0,
970,Future Opportunities,1.0,0.0,0.0,
971,Customer Protection,1.0,0.0,0.0,
972,Product Reliability,1.0,0.0,0.0,
973,Securities Servicing,1.0,0.0,0.0,
974,Private Banking Revenues,0.0,0.0,1.0,
975,Operating Profit,1.0,0.0,0.0,
976,Competitive Position,2.0,0.0,1.0,
977,Customer Response,1.0,0.0,0.0,
978,Deposit Growth,1.0,0.0,0.0,
979,Trade Tensions,0.0,0.0,1.0,
980,Pension Contributions,0.0,1.0,0.0,
981,Long-term Liabilities,0.0,1.0,0.0,
982,Regulatory Compliance,1.0,1.0,0.0,
983,Risk Profile,1.0,0.0,0.0,
984,Nonperforming Status,0.0,0.0,1.0,
985,Financial Condition,1.0,0.0,2.0,
986,Claims,0.0,1.0,0.0,
987,Allowance for Credit Losses,0.0,0.0,1.0,
988,Perception,0.0,0.0,2.0,
989,Technology Advancements,1.0,0.0,0.0,
990,Innovations,1.0,0.0,0.0,
991,Market Potential,3.0,0.0,0.0,
992,Royalty Structure,1.0,0.0,0.0,
993,Negotiation Rights,1.0,0.0,0.0,
994,Royalty,1.0,0.0,0.0,
995,Investor Attention,1.0,0.0,0.0,
996,Therapeutic Window,1.0,0.0,0.0,
997,Market Attention,1.0,0.0,0.0,
998,Clinical Trial,1.0,0.0,0.0,
999,Volume Mix,0.0,0.0,1.0,
1000,Opex,0.0,0.0,1.0,
1001,Buyback,2.0,0.0,0.0,
1002,Sales & Marketing,0.0,1.0,0.0,
1003,General & Administrative,0.0,1.0,0.0,
1004,Active Accounts,1.0,0.0,0.0,
1005,Patent,0.0,0.0,1.0,
1006,Patent Effectiveness,1.0,0.0,0.0,
1007,Patent Litigation,0.0,0.0,1.0,
1008,Legal Strategy,1.0,0.0,0.0,
1009,Trial Outcome,1.0,0.0,0.0,
1010,Patent Validity,0.0,1.0,0.0,
1011,Expert Opinion,1.0,0.0,0.0,
1012,Direct-to-Consumer,1.0,0.0,0.0,
1013,Digital Transformation,5.0,0.0,0.0,
1014,Interest Expense,0.0,0.0,1.0,
1015,EPS Headwind,0.0,0.0,1.0,
1016,Shipments,1.0,0.0,0.0,
1017,Positioning,1.0,0.0,0.0,
1018,Product Commercialization,1.0,0.0,0.0,
1019,Trial Progress,0.0,2.0,0.0,
1020,Logistical Issues,0.0,0.0,1.0,
1021,Market Growth,2.0,0.0,0.0,
1022,Market Size,1.0,0.0,0.0,
1023,Regulatory Environment,0.0,1.0,0.0,
1024,Community Outreach,1.0,0.0,0.0,
1025,Product Portfolio,2.0,0.0,0.0,
1026,Strategic Initiatives,1.0,0.0,0.0,
1027,Total Return,0.0,0.0,1.0,
1028,Speed of Service,0.0,0.0,1.0,
1029,Labor Turnover,0.0,0.0,1.0,
1030,Menu Complexity,0.0,0.0,1.0,
1031,Transaction Growth,2.0,0.0,1.0,
1032,Portfolio Positioning,2.0,0.0,0.0,
1033,Discounts,1.0,1.0,2.0,
1034,Community Engagement,1.0,0.0,0.0,
1035,Membership Growth,1.0,0.0,0.0,
1036,Ecosystem Development,1.0,0.0,0.0,
1037,Marketing Efficiency,1.0,0.0,0.0,
1038,Category Expansion,1.0,0.0,0.0,
1039,Freight Costs,0.0,0.0,1.0,
1040,Operational Footprint,0.0,1.0,0.0,
1041,Data Accuracy,0.0,0.0,1.0,
1042,Investor Caution,0.0,0.0,1.0,
1043,Rebates,1.0,0.0,0.0,
1044,Traffic Recovery,0.0,1.0,0.0,
1045,Delivery Timing,0.0,0.0,1.0,
1046,US-China Relations,0.0,1.0,0.0,
1047,Management Plans,0.0,1.0,0.0,
1048,Productivity Savings,1.0,0.0,0.0,
1049,Recurring Revenue,2.0,0.0,0.0,
1050,Operating Margins,0.0,0.0,1.0,
1051,Training Requirements,0.0,0.0,1.0,
1052,Funding Impact,0.0,0.0,1.0,
1053,Political Positioning,0.0,1.0,0.0,
1054,Earnings Yield,0.0,1.0,0.0,
1055,Momentum,0.0,0.0,1.0,
1056,ETFs,1.0,0.0,0.0,
1057,Inflows,1.0,0.0,0.0,
1058,Performance Enhancements,1.0,0.0,0.0,
1059,Architecture Strategy,1.0,0.0,0.0,
1060,Roadmap Clarity,1.0,0.0,0.0,
1061,Technological Focus,1.0,0.0,0.0,
1062,Architecture,1.0,0.0,0.0,
1063,Performance Improvement,1.0,0.0,0.0,
1064,Architecture Innovation,1.0,0.0,0.0,
1065,Power Management,1.0,0.0,0.0,
1066,AI Capabilities,1.0,0.0,0.0,
1067,Power Efficiency,1.0,0.0,0.0,
1068,Portfolio Optimization,1.0,0.0,0.0,
1069,Brand Management,0.0,0.0,1.0,
1070,Input Prices,0.0,0.0,1.0,
1071,Operating Performance,1.0,0.0,1.0,
1072,Promotional Environment,0.0,0.0,1.0,
1073,Employee Engagement,2.0,0.0,0.0,
1074,FICC Performance,0.0,0.0,1.0,
1075,Volume Recovery,3.0,0.0,0.0,
1076,Spending,1.0,0.0,0.0,
1077,AI Implementation,1.0,0.0,0.0,
1078,Management Risk,0.0,0.0,1.0,
1079,Technical Debt,0.0,0.0,1.0,
1080,Strategic Threat,0.0,0.0,1.0,
1081,Actions,1.0,0.0,0.0,
1082,Financial Risk,0.0,0.0,1.0,
1083,Technology Spending,0.0,0.0,2.0,
1084,Impact,0.0,1.0,0.0,
1085,Use Cases,1.0,0.0,0.0,
1086,Cloud,0.0,0.0,1.0,
1087,Data Management,1.0,0.0,1.0,
1088,Cloud Strategy,0.0,1.0,0.0,
1089,Reputational Risks,0.0,0.0,1.0,
1090,Operating Environment,1.0,0.0,1.0,
1091,Core Results,1.0,0.0,0.0,
1092,Trip Compliance,0.0,1.0,0.0,
1093,Freight Velocity,1.0,0.0,0.0,
1094,Dwell Time,1.0,0.0,0.0,
1095,Train Length,1.0,0.0,0.0,
1096,Infrastructure Development,1.0,0.0,0.0,
1097,Overall Positioning,1.0,0.0,0.0,
1098,Network Deployment,1.0,0.0,0.0,
1099,C-Band Build,1.0,0.0,0.0,
1100,Accretion,1.0,0.0,0.0,
1101,E-commerce Growth,1.0,0.0,0.0,
1102,Recovery Dynamics,1.0,0.0,0.0,
1103,Customer Growth,2.0,0.0,0.0,
1104,Loyalty,1.0,0.0,0.0,
1105,Store Execution,1.0,0.0,0.0,
1106,Financial Outlook,0.0,0.0,1.0,
1107,Brand Awareness,3.0,0.0,0.0,
1108,Branding,1.0,0.0,0.0,
1109,Risk Reward,0.0,1.0,1.0,
1110,Buyback Guidance,1.0,0.0,0.0,
1111,Capital Discipline,2.0,0.0,0.0,
1112,Energy Transition,4.0,0.0,0.0,
1113,Financial Leverage,2.0,0.0,0.0,
1114,Service Levels,0.0,0.0,1.0,
1115,Profit Forecast,0.0,0.0,1.0,
1116,Structural Issues,0.0,0.0,1.0,
1117,Upside Risk,1.0,0.0,0.0,
1118,Business Enhancement,1.0,0.0,0.0,
1119,Operational Turnaround,2.0,0.0,0.0,
1120,Product Cadence,2.0,0.0,0.0,
1121,Consumer Sentiment,2.0,0.0,2.0,
1122,Product Offerings,2.0,0.0,0.0,
1123,Savings Opportunities,1.0,0.0,0.0,
1124,Loan Loss,0.0,0.0,2.0,
1125,Support for Businesses,1.0,0.0,0.0,
1126,Community Commitment,1.0,0.0,0.0,
1127,Loan Demand,0.0,0.0,1.0,
1128,NCOs,0.0,0.0,1.0,
1129,Emerging Markets,0.0,1.0,0.0,
1130,Debt Issuance,1.0,0.0,0.0,
1131,Equity Issuance,1.0,0.0,1.0,
1132,Loan Issuance,0.0,0.0,1.0,
1133,Sovereign Risks,0.0,0.0,1.0,
1134,Study Outcomes,0.0,0.0,1.0,
1135,Commodity Prices,1.0,0.0,2.0,
1136,Currency Movements,0.0,0.0,1.0,
1137,Tax Issues,0.0,0.0,1.0,
1138,Industry Position,1.0,0.0,0.0,
1139,Tax Stability,1.0,0.0,0.0,
1140,Fintech Position,1.0,0.0,0.0,
1141,Payment Processing,0.0,0.0,1.0,
1142,Repossession,0.0,0.0,1.0,
1143,GAP Fees,0.0,0.0,1.0,
1144,Franchisee Support,2.0,0.0,0.0,
1145,Delivery Economics,0.0,0.0,1.0,
1146,Franchisee Profitability,0.0,0.0,1.0,
1147,Promotional Strategy,1.0,0.0,1.0,
1148,Franchisee Relations,1.0,0.0,0.0,
1149,Commercial Opportunities,0.0,0.0,1.0,
1150,Consumer,0.0,0.0,2.0,
1151,Union Dynamics,0.0,1.0,0.0,
1152,Therapeutics,1.0,0.0,0.0,
1153,Reporting Method,0.0,1.0,0.0,
1154,Execution Challenges,0.0,0.0,1.0,
1155,Business Conditions,0.0,1.0,0.0,
1156,Gross Margin,1.0,0.0,0.0,
1157,Household Formation,1.0,0.0,0.0,
1158,Local Offers,0.0,0.0,1.0,
1159,Weather Impact,0.0,0.0,1.0,
1160,Expense Program,1.0,0.0,0.0,
1161,Loan Balances,0.0,0.0,1.0,
1162,Credit Concerns,0.0,0.0,1.0,
1163,Management Tone,1.0,0.0,0.0,
1164,Backlog,1.0,0.0,0.0,
1165,Customer Wins,1.0,0.0,0.0,
1166,Sales Force,1.0,0.0,0.0,
1167,International Opportunity,1.0,0.0,0.0,
1168,Approval Process,1.0,0.0,0.0,
1169,Market Strategy,1.0,1.0,0.0,
1170,Outsourcing Impact,0.0,0.0,1.0,
1171,Loan Losses,0.0,0.0,1.0,
1172,Tax Settlement,1.0,0.0,0.0,
1173,Divestiture,0.0,1.0,0.0,
1174,Price/Mix,0.0,1.0,0.0,
1175,Capitalization,1.0,0.0,0.0,
1176,Concerns,0.0,0.0,3.0,
1177,Pension Obligations,1.0,0.0,0.0,
1178,Buyback Announcement,1.0,0.0,0.0,
1179,Investment Strategy,1.0,0.0,0.0,
1180,Resource Base,1.0,0.0,0.0,
1181,Portfolio Management,2.0,0.0,0.0,
1182,Merchandising,3.0,0.0,0.0,
1183,Traffic Trends,1.0,0.0,0.0,
1184,E-commerce Infrastructure,1.0,0.0,0.0,
1185,Velocity,1.0,0.0,0.0,
1186,Membership Fees,0.0,1.0,0.0,
1187,Employee Tenure,1.0,0.0,0.0,
1188,Travel,0.0,0.0,1.0,
1189,Delivery Efficiency,1.0,0.0,0.0,
1190,Cyclical Risk,0.0,0.0,1.0,
1191,Earnings Generation,1.0,0.0,0.0,
1192,Margin Targets,0.0,1.0,0.0,
1193,Price/Mix Normalization,0.0,1.0,0.0,
1194,Earnings Stability,1.0,0.0,0.0,
1195,Unit Sales,0.0,0.0,1.0,
1196,Earnings Pressure,0.0,0.0,2.0,
1197,Predictability,4.0,0.0,0.0,
1198,Forecasting,1.0,0.0,0.0,
1199,Business Process,1.0,0.0,0.0,
1200,Customer Value,1.0,0.0,0.0,
1201,Customer Focus,1.0,0.0,0.0,
1202,Market Adoption,1.0,0.0,0.0,
1203,Enablement,1.0,0.0,0.0,
1204,Best Practices,1.0,0.0,0.0,
1205,Retained Value,0.0,0.0,1.0,
1206,Loan Program,1.0,0.0,0.0,
1207,Customer Dependency,0.0,0.0,1.0,
1208,Differentiation,1.0,0.0,0.0,
1209,Capital Adequacy,1.0,0.0,0.0,
1210,Specialization,1.0,0.0,0.0,
1211,Dealer Network,0.0,1.0,0.0,
1212,Treatment Effects,0.0,0.0,1.0,
1213,Patient Impact,0.0,0.0,1.0,
1214,Cloud Demand,1.0,0.0,0.0,
1215,Pricing Outlook,1.0,0.0,0.0,
1216,International Growth,1.0,0.0,0.0,
1217,EBITDA Estimates,1.0,0.0,0.0,
1218,Merger,0.0,0.0,2.0,
1219,Capacity Expansion,1.0,0.0,0.0,
1220,Resource Allocation,1.0,0.0,0.0,
1221,Vendor Relations,1.0,0.0,0.0,
1222,Software Strategy,1.0,0.0,0.0,
1223,Battery Technology,1.0,0.0,0.0,
1224,Range,1.0,0.0,0.0,
1225,Customer Insights,1.0,0.0,0.0,
1226,Product Cycle,1.0,0.0,0.0,
1227,Store Closures,0.0,0.0,1.0,
1228,Buyback Program,1.0,0.0,0.0,
1229,EPS Accretion,1.0,0.0,0.0,
1230,Regulatory Risk,0.0,0.0,2.0,
1231,Commodity Inflation,0.0,0.0,1.0,
1232,Product Updates,1.0,0.0,0.0,
1233,Transaction Impact,1.0,0.0,0.0,
1234,Short-term Impact,0.0,0.0,1.0,
1235,Federal Lending,0.0,1.0,0.0,
1236,Sales Guidance,0.0,0.0,1.0,
1237,Franchisee,1.0,0.0,0.0,
1238,Foreign Exchange,1.0,0.0,0.0,
1239,Turnaround,1.0,0.0,0.0,
1240,Franchise Contribution,1.0,0.0,0.0,
1241,Store Reopening,1.0,0.0,0.0,
1242,Digital Demand,1.0,0.0,0.0,
1243,Merchandise Margin,0.0,0.0,1.0,
1244,Operational Consolidation,1.0,0.0,0.0,
1245,Opportunistic Entry,0.0,1.0,0.0,
1246,Funding Needs,0.0,0.0,1.0,
1247,Payout Ratio,0.0,0.0,3.0,
1248,Financial Flexibility,0.0,0.0,1.0,
1249,Investment Activity,0.0,0.0,2.0,
1250,Subscriber Decline,0.0,0.0,1.0,
1251,Revenue Decline,0.0,0.0,1.0,
1252,EBITDA Decline,0.0,0.0,1.0,
1253,Network Efficiency,1.0,0.0,0.0,
1254,Interest Income,1.0,0.0,0.0,
1255,Share Price Performance,0.0,0.0,1.0,
1256,Return On Capital,1.0,0.0,1.0,
1257,Business Quality,1.0,0.0,0.0,
1258,Dividend,2.0,0.0,0.0,
1259,Oil Prices,0.0,0.0,1.0,
1260,Portfolio,1.0,0.0,0.0,
1261,Refining,1.0,0.0,0.0,
1262,Chemicals,1.0,0.0,0.0,
1263,Brand Strategy,1.0,0.0,0.0,
1264,Consumer Connectivity,1.0,0.0,0.0,
1265,Online Sales,1.0,0.0,0.0,
1266,Earnings Guidance,0.0,0.0,1.0,
1267,Gross Profits,0.0,0.0,1.0,
1268,Accounts Payable,0.0,0.0,1.0,
1269,Fraud Detection,1.0,0.0,0.0,
1270,Capital Access,1.0,0.0,0.0,
1271,Operational Growth,1.0,0.0,0.0,
1272,Management Assumptions,1.0,0.0,1.0,
1273,Trading Income,0.0,1.0,0.0,
1274,Funding Costs,1.0,0.0,0.0,
1275,Production Constraints,0.0,0.0,1.0,
